142 related articles for article (PubMed ID: 1988778)
1. The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones.
Hassager C; Jensen LT; Johansen JS; Riis BJ; Melkko J; Pødenphant J; Risteli L; Christiansen C; Risteli J
Metabolism; 1991 Feb; 40(2):205-8. PubMed ID: 1988778
[TBL] [Abstract][Full Text] [Related]
2. The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy.
Hassager C; Jensen LT; Pødenphant J; Thomsen K; Christiansen C
Calcif Tissue Int; 1994 Jan; 54(1):30-3. PubMed ID: 8118750
[TBL] [Abstract][Full Text] [Related]
3. Collagen synthesis in postmenopausal women during therapy with anabolic steroid or female sex hormones.
Hassager C; Jensen LT; Pødenphant J; Riis BJ; Christiansen C
Metabolism; 1990 Nov; 39(11):1167-9. PubMed ID: 2233278
[TBL] [Abstract][Full Text] [Related]
4. Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?
Johansen JS; Hassager C; Pødenphant J; Riis BJ; Hartwell D; Thomsen K; Christiansen C
Bone Miner; 1989 Apr; 6(1):77-86. PubMed ID: 2665884
[TBL] [Abstract][Full Text] [Related]
5. Effects of nandrolone decanoate on bone mass in established osteoporosis.
Passeri M; Pedrazzoni M; Pioli G; Butturini L; Ruys AH; Cortenraad MG
Maturitas; 1993 Nov; 17(3):211-9. PubMed ID: 8133796
[TBL] [Abstract][Full Text] [Related]
6. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys.
Jerome CP; Power RA; Obasanjo IO; Register TC; Guidry M; Carlson CS; Weaver DS
Bone; 1997 Apr; 20(4):355-64. PubMed ID: 9108356
[TBL] [Abstract][Full Text] [Related]
7. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
Gennari C; AgnusDei D; Gonnelli S; Nardi P
Maturitas; 1989 Sep; 11(3):187-97. PubMed ID: 2687645
[TBL] [Abstract][Full Text] [Related]
8. [Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].
Gennari C; Agnusdei D; Gonnelli S
Minerva Endocrinol; 1989; 14(1):69-74. PubMed ID: 2659955
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D metabolism in osteoporotic women during treatment with estrogen, an anabolic steroid, or calcitonin.
Hartwell D; Hassager C; Overgaard K; Riis BJ; Pødenphant JR; Christiansen C
Acta Endocrinol (Copenh); 1990 Jun; 122(6):715-21. PubMed ID: 2375235
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
Mauras N; Doi SQ; Shapiro JR
J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
[TBL] [Abstract][Full Text] [Related]
11. Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
Francini G; Gonnelli S; Petrioli R; Bruni S; Marsili S; Aquino A; Camporeale A
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):125-9. PubMed ID: 8467247
[TBL] [Abstract][Full Text] [Related]
12. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
[TBL] [Abstract][Full Text] [Related]
13. Continuously combined hormone replacement therapy and bone turnover: the influence of dydrogesterone dose, smoking and initial degree of bone turnover.
de Valk-de Roo GW; Netelenbos JC; Peters-Muller IR; Voetberg GA; van de Weijer PH; Bouman AA; Popp-Snijders C; Kenemans P
Maturitas; 1997 Dec; 28(2):153-62. PubMed ID: 9522323
[TBL] [Abstract][Full Text] [Related]
14. A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women.
Bird HA; Burkinshaw L; Pearson D; Atkinson PJ; Leatham PA; Hill J; Raven A; Wright V
Ann Rheum Dis; 1987 Mar; 46(3):237-43. PubMed ID: 3555359
[TBL] [Abstract][Full Text] [Related]
15. Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis.
Need AG; Horowitz M; Walker CJ; Chatterton BE; Chapman IC; Nordin BE
Bone; 1989; 10(1):3-6. PubMed ID: 2736154
[TBL] [Abstract][Full Text] [Related]
16. Effects of nandrolone therapy on forearm bone mineral content in osteoporosis.
Need AG; Horowitz M; Morris HA; Walker CJ; Nordin BE
Clin Orthop Relat Res; 1987 Dec; (225):273-8. PubMed ID: 3677513
[TBL] [Abstract][Full Text] [Related]
17. Effects of a combined estrogen-gestagen regimen on serum levels of the carboxy-terminal propeptide of human type I procollagen in osteoporosis.
Hasling C; Eriksen EF; Melkko J; Risteli L; Charles P; Mosekilde L; Risteli J
J Bone Miner Res; 1991 Dec; 6(12):1295-300. PubMed ID: 1724340
[TBL] [Abstract][Full Text] [Related]
18. Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women.
Need AG; Morris HA; Hartley TF; Horowitz M; Nordin BE
Calcif Tissue Int; 1987 Jul; 41(1):7-10. PubMed ID: 3113703
[TBL] [Abstract][Full Text] [Related]
19. Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women.
Need AG; Horowitz M; Bridges A; Morris HA; Nordin BE
Arch Intern Med; 1989 Jan; 149(1):57-60. PubMed ID: 2912415
[TBL] [Abstract][Full Text] [Related]
20. Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate.
Need AG; Nordin BE; Chatterton BE
Osteoporos Int; 1993; 3 Suppl 1():218-22. PubMed ID: 8461566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
